1. Experimental Pathology and Therapeutics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal
2. New Therapies Group, INEB-Institute for Biomedical Engineering, Porto, Portugal
3. Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Portugal
4. Institute of Biomedical Sciences Abel Salazar, University of Porto, Porto, Portugal
5. Biomaterials for Multistage Drug and Cell Delivery, INEB-Institute for Biomedical Engineering, Porto, Portugal
6. Glycobiology in Cancer, Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
7. Department of Pathology, Hospital Pedro Hispano, Matosinhos, Portugal
8. LAQV-REQUIMTE, Faculty of Sciences of the University of Porto, Porto, Portugal
9. Health School of University Fernando Pessoa, Porto, Portugal
10. UCIBIO-REQUIMTE, Instituto de Ciências Biomédicas Abel Salazar, University of Porto, Porto, Portugal
11. UCIBIO-REQUIMTE/Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, Porto, Portugal
12. Department of Pathology and Oncology, Faculty of Medicine, Porto University, Porto, Portugal
13. Department of Surgical Oncology, Portuguese Institute of Oncology, Porto, Portugal
14. Porto Comprehensive Cancer Center (P.ccc), Porto, Portugal